JP2019513769A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513769A5
JP2019513769A5 JP2018553392A JP2018553392A JP2019513769A5 JP 2019513769 A5 JP2019513769 A5 JP 2019513769A5 JP 2018553392 A JP2018553392 A JP 2018553392A JP 2018553392 A JP2018553392 A JP 2018553392A JP 2019513769 A5 JP2019513769 A5 JP 2019513769A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
mucosa
strain
composition according
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018553392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513769A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/028133 external-priority patent/WO2017184601A1/en
Publication of JP2019513769A publication Critical patent/JP2019513769A/ja
Publication of JP2019513769A5 publication Critical patent/JP2019513769A5/ja
Pending legal-status Critical Current

Links

JP2018553392A 2016-04-19 2017-04-18 アトピー性皮膚炎を処置するためのグラム陰性種の使用 Pending JP2019513769A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662324762P 2016-04-19 2016-04-19
US62/324,762 2016-04-19
PCT/US2017/028133 WO2017184601A1 (en) 2016-04-19 2017-04-18 Use of gram negative species to treat atopic dermatitis

Publications (2)

Publication Number Publication Date
JP2019513769A JP2019513769A (ja) 2019-05-30
JP2019513769A5 true JP2019513769A5 (enExample) 2020-05-21

Family

ID=58708000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018553392A Pending JP2019513769A (ja) 2016-04-19 2017-04-18 アトピー性皮膚炎を処置するためのグラム陰性種の使用

Country Status (11)

Country Link
US (8) US10195236B2 (enExample)
EP (2) EP3445330B1 (enExample)
JP (1) JP2019513769A (enExample)
KR (1) KR102340006B1 (enExample)
CN (1) CN109310626A (enExample)
AU (2) AU2017253935B2 (enExample)
CA (1) CA3020863A1 (enExample)
IL (1) IL262455A (enExample)
MX (1) MX2018012719A (enExample)
SG (1) SG11201809100QA (enExample)
WO (1) WO2017184601A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6494233B2 (ja) * 2013-10-03 2019-04-03 日東電工株式会社 粘膜ワクチン組成物
CN115919906A (zh) 2016-03-04 2023-04-07 加利福尼亚大学董事会 微生物聚生体及其用途
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
EP3445330B1 (en) 2016-04-19 2022-07-06 The U.S.A. as represented by the Secretary, Department of Health and Human Services Use of gram negative species to treat atopic dermatitis
MX2020005875A (es) 2017-12-05 2020-10-08 Bioplx Inc Métodos y composiciones para prevenir la infección microbiana.
AU2019253714A1 (en) 2018-04-10 2020-11-26 Siolta Therapeutics, Inc. Microbial consortia
US20190321416A1 (en) * 2018-04-18 2019-10-24 Forte Biosciences, Inc. Compositions for the treatment of skin conditions
GB2588721A (en) * 2018-05-11 2021-05-05 Forte Subsidiary Inc Compositions for the treatment of skin conditions
AU2018433819A1 (en) * 2018-07-23 2021-03-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
KR102691625B1 (ko) 2022-04-19 2024-08-06 코스맥스 주식회사 세디미니박테리움 락티스 균주 및 그의 피부 상태 개선 용도
KR102691627B1 (ko) 2022-04-19 2024-08-06 코스맥스 주식회사 로제오모나스 뮤코사 균주 및 그의 피부 상태 개선 용도
CN117247928A (zh) * 2022-06-10 2023-12-19 中国科学院天津工业生物技术研究所 一种头孢菌素c酰化酶催化的酰化反应及其应用
CN115140846B (zh) * 2022-07-06 2024-06-21 江苏聚庚科技股份有限公司 一种复合处理剂、制备方法及其在净化废水中的应用
CN116139163B (zh) * 2023-03-22 2023-09-05 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 一种粘液玫瑰单胞菌胞外多糖在制备用于缓解特应性皮炎的药物上的应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1019523A (en) 1910-03-14 1912-03-05 Maxmillian E Primbs Ironing-table.
US1020695A (en) 1911-11-17 1912-03-19 Hess Mfg Co Drier.
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832253A (en) 1973-03-21 1974-08-27 Baxter Laboratories Inc Method of making an inflatable balloon catheter
US4667014A (en) 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
KR100374462B1 (ko) 1993-10-22 2003-06-09 스미스클라인 비참 코포레이션 신규조성물
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6218371B1 (en) 1998-04-03 2001-04-17 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
US6974585B2 (en) 2001-08-01 2005-12-13 Medlogic Global Limited Durable multi-component antibiotic formulation for topical use
US20030100034A1 (en) 2001-10-16 2003-05-29 Millennium Pharmaceuticals, Inc. 9136, a human aldehyde dehydrogenase family member and uses therefor
DE10158712A1 (de) * 2001-11-29 2003-06-26 Umwelttechnik Georg Fritzmeier Zusammensetzung zur Behandlung der Hautoberfläche
KR100536522B1 (ko) * 2003-03-07 2005-12-14 (주)바이오솔루션 인간 피부 유래의 신규한 박테리오신 및 여드름치료제로서의 용도
ATE511848T1 (de) * 2004-08-25 2011-06-15 Us Gov Health & Human Serv Lebendige mikrobielle mikrobizide
JP2006131622A (ja) 2004-10-05 2006-05-25 Genichiro Soma 薬剤
KR20070091613A (ko) 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
EP1736537A1 (en) 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
PL2448577T3 (pl) 2009-06-30 2017-02-28 Derman Biomedicine Co. Ltd. Kompozycje zawierające berberynę lub jej analogi do leczenia trądziku różowatego lub chorób skóry związanych z zaczerwienieniem twarzy
US9050319B2 (en) 2010-04-30 2015-06-09 Telormedix, Sa Phospholipid drug analogs
WO2012150269A1 (en) 2011-05-03 2012-11-08 Dupont Nutrition Biosciences Aps Probiotic bacteria for the topical treatment of skin disorders
US20130121968A1 (en) 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
IN2014DN07752A (enExample) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
GB201206599D0 (en) 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
US9283983B2 (en) 2013-01-15 2016-03-15 Nsk Ltd. Tilt steering system
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CN106456678A (zh) 2014-04-15 2017-02-22 Ao生物医学有限责任公司 氨氧化型亚硝化单胞菌菌株d23
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US9526201B2 (en) 2015-01-05 2016-12-27 Cnh Industrial America Llc Twin-row planter with tandem driven seed meters
WO2016172196A1 (en) 2015-04-20 2016-10-27 Pätzold Bernhard Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
EP3445330B1 (en) 2016-04-19 2022-07-06 The U.S.A. as represented by the Secretary, Department of Health and Human Services Use of gram negative species to treat atopic dermatitis
US10695386B2 (en) 2017-05-11 2020-06-30 Shayne K. Morris Skin microbiome colonizer formulations and methods for use
US20190321416A1 (en) 2018-04-18 2019-10-24 Forte Biosciences, Inc. Compositions for the treatment of skin conditions
GB2588721A (en) 2018-05-11 2021-05-05 Forte Subsidiary Inc Compositions for the treatment of skin conditions
AU2018433819A1 (en) 2018-07-23 2021-03-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis

Similar Documents

Publication Publication Date Title
BR112018001811A2 (pt) composição de bactérias láticas para uso no tratamento de infecções devidas a pro-pionibacterium acnes e em particular para acne
WO2015066647A3 (en) Ionic liquids for transdermal drug delivery
CA3006294A1 (en) Combinations of rapamycin and metformin for the treatment of joint and skin diseases
JP6429131B2 (ja) 膣症を予防および治療するために塩および糖を有効成分として含む皮膚外用組成物およびその使用
JP2016507532A5 (enExample)
JP2022501330A5 (enExample)
PH12020500543A1 (en) Nonracemic mixtures and uses thereof
RU2014142038A (ru) Короткие антимикробные липопептиды
JP2015535214A5 (enExample)
JP2020525460A5 (enExample)
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
MX2022001736A (es) Formulaciones y tratamientos topicos.
GB2593281A (en) Use of gram negative species to treat atopic dermatitis
WO2016063265A3 (pt) Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos
JP2013523789A5 (enExample)
CN103948607A (zh) 杀菌抑菌冻疮膏
CN104815103A (zh) 拔毒散
Fanting et al. Pharmacodynamic study of different formulations of gynecological ice snake
Yadav et al. Management of burns in bovine: A clinical study
RU2020102673A (ru) Антибактериальная активность галактоолигосахарида и ксилита в дерматологических лечениях
Kashcheyeva et al. Prospects for the use of bacteriophages in cosmetology for the prevention of skin diseases
CN104644682A (zh) 治疗化脓性中耳炎的中药配方
Verkhovodova In vitro study of antimicrobal activity of some salvia officinalis extracts
CN106728021A (zh) 一种金疮药
Starzhinskaya et al. Improvement of extemporaneous ointment with wound healing action